Published in Food and Drug Law Weekly, January 15th, 2010
Vion will evaluate whether to file another SPA for an alternative randomized Phase III...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.